Publication - Regulation/directive/order

Coronavirus (COVID-19) vaccine - Comirnaty® (mRNA Vaccine, Pfizer/BioNTech): national protocol

Published: 4 February 2022
Directorate: Chief Operating Officer, NHS Scotland Directorate
Part of: Coronavirus (COVID-19) in Scotland, Health and social care, Public safety and emergencies
ISBN: 9781802019957

Protocol guidance Comirnaty® (COVID-19 mRNA Vaccine, Pfizer/BioNTech).

5. Clinical condition or situation to which this Protocol applies

Comirnaty® (COVID-19 mRNA Vaccine, Pfizer/BioNTech) is indicated for active immunisation against COVID-19 disease caused by SARS-CoV-2 virus in accordance with Scottish Government COVID-19 immunisation programme and recommendations given in Chapter 14a of the Immunisation Against Infectious Disease: COVID-19: the green book, chapter 14a - GOV.UK (www.gov.uk) and Scottish Government CMO letters relating to COVID-19 vaccination.

Contact

Email: CEU@gov.scot

There is a problem

Thanks for your feedback

Was this helpful?

Yes

Your comments

Your feedback helps us to improve this website. Do not give any personal information because we cannot reply to you directly.

Choose a reason for your feedback

Your comments

Your feedback helps us to improve this website. Do not give any personal information because we cannot reply to you directly.

Yes, but

Choose a reason for your feedback

Your comments

Your feedback helps us to improve this website. Do not give any personal information because we cannot reply to you directly.

Information

5. Clinical condition or situation to which this Protocol applies

Contact

There is a problem